Trial Profile
Compassionate Use of Veliparib (ABT-888) for the Treatment of Recurrent Ovarian Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 May 2013
Price :
$35
*
At a glance
- Drugs Veliparib (Primary) ; Temozolomide
- Indications Ovarian cancer
- Focus Therapeutic Use
- 03 May 2013 New trial record